Skip to content
Topics
Stories

Researchers are taking aim at the counterfeit drug and medical supplies market

People in this story

Photo by Matthew Modoono/Northeastern University

The skyrocketing demand for COVID-19 treatment has scientists working overtime to produce medicines and vaccines. But simply creating these therapies isn’t the only hurdle facing researchers and world leaders. 

Once a vaccine is developed, for example, it will inevitably be in short supply. And if rich countries continue to monopolize doses, poorer countries will be left to fend for themselves.  

Situations like this fuel the counterfeit drug market, says Nikos Passas, professor of criminology and criminal justice at Northeastern. When people are desperate, they’ll take whatever treatments they can get. And that can be incredibly dangerous to people’s health.

Continue reading at News@Northeastern.

More Stories

Supreme Court nominee Amy Coney Barrett speaks during a confirmation hearing before the Senate Judiciary Committee, Wednesday, Oct. 14, 2020, on Capitol Hill in Washington.

Amy Coney Barrett is poised to continue Antonin Scalia’s legacy on the supreme court

10.26.2020

Lasting police reform will require confronting roots of racism in American policing

10.26.2020

Are COVID-19 vaccine trials ethical?

10.26.20
All Stories